title: Tissue expression of TGF-β1 in uterine cervical samples from HIV/AIDS patients.
abstract: Case-control study based on the immunohistochemistry for TGF-β1 evaluation of cervical samples obtained from two groups of women: CIN/HIV- and CIN/HIV+. Eleven women infected with HIV and with a histopathological diagnosis of CIN were included. The control group consisted of 12 patients with CIN. Cervical tissue samples obtained from all patients were submitted to histopathology and semiquantitative analysis of immunostaining for TGF-β1 protein. In addition, the peripheral CD4+ cell count and viral load were evaluated in HIV + patients. Tissue expression of the cytokine was higher in the CIN/HIV+ group compared to control (p = 0.0023). In addition, higher TGF-β1 expression was observed in higher grade cervical lesions in the two groups. There was a trend toward a direct correlation between peripheral CD4+ T cell count and tissue TGF-β1, and toward an inverse correlation between viral load and cytokine expression. Thus, TGF-β1 was more marked in situations in which cervical lesions are known to present a more aggressive behavior, suggesting that this cytokine is involved in the pathogenesis of tumor growth in these lesions. Tissue expression of TGF-β1 is increased in cervical samples from HIV-infected women with CIN.
authors.affiliation: Centro de Ciencias Biologicas e da Saude, Universidade do Estado do Para, Belem, Para, Brazil.
authors.forename: Thiago X
authors.initials: TX
authors.lastname: Carneiro
authors.forename: Juliana T
authors.initials: JT
authors.lastname: Pacheco
authors.forename: Marilia B
authors.initials: MB
authors.lastname: Xavier
authors.forename: Juarez A S
authors.initials: JA
authors.lastname: Quaresma
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000276:immunology / Q000473:pathology*; D000328:Adult; D018791:CD4 Lymphocyte Count; D016022:Case-Control Studies; D002584:Cervix Uteri / Q000473:pathology*; D005260:Female; D015870:Gene Expression; D006678:HIV / Q000302:isolation & purification; D006801:Humans; D007150:Immunohistochemistry; D053773:Transforming Growth Factor beta1 / Q000096:biosynthesis*; D019562:Viral Load; D002578:Uterine Cervical Dysplasia / Q000150:complications* / Q000276:immunology / Q000473:pathology*
chemical_list: D053773:Transforming Growth Factor beta1